Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The development of next generation sequencing (NGS) has radically transformed the scientific landscape, making it possible to sequence the exome of any given individual in a cost-effective way. The power of this approach has been demonstrated by a number of groups who have identified pathogenic mutations in small pedigrees that have been resistant to traditional genetic mapping. Recently it has become clear that exome sequencing has great potential with respect to sporadic disease and the identification of de novo mutations. This is highlighted by studies reporting whole-exome sequencing of patient-parental trios affected by learning disability, autism and schizophrenia. It is widely anticipated that the introduction of this technique into a clinical setting will revolutionise genetic diagnosis. However, the sensitivity of NGS exome sequencing is currently unclear. Here, we describe the exome sequencing of DNA samples from a patient with double cortex syndrome and her parents, resulting in the detection of a mosaic splicing mutation in LIS1. This variant was found at an allele frequency of just 18%, demonstrating that NGS methods have the capacity to identify pathogenic mosaic mutations present at a low level.

Original publication

DOI

10.1038/jhg.2011.128

Type

Journal article

Journal

J Hum Genet

Publication Date

01/2012

Volume

57

Pages

70 - 72

Keywords

1-Alkyl-2-acetylglycerophosphocholine Esterase, Amino Acid Sequence, Base Sequence, Child, Classical Lissencephalies and Subcortical Band Heterotopias, Exome, Female, Gene Frequency, Humans, Magnetic Resonance Imaging, Microtubule-Associated Proteins, Molecular Sequence Data, Mosaicism, Sequence Analysis, DNA